CCIRC Fears Multimodality Studies Threatened By Cooperative Groups’ Misapplication Of Funds
In Brief: Carter Wants His Own Man, So Cooper Is Out; New Preventive Oncology Society Established
NCI, FDA Near Agreement On INDs; Young, Hoogstraten Clash On Rubidazone
Brown’s appointment may Be Delayed Until After Jan. 20
Big Community Programs Under Way In Detroit, N.M.; Others Near OK
Trending Stories
- Oncologist Rachna Shroff endows award to outlast her cancer diagnosis
“Because of my health, I have a profound desire to see this endowment come to fruition now” - Is it time to re-assess the practice and practicality of screening colonoscopy?
Modeling data, ACS guideline support greater use of noninvasive tests to ease system strain, help save lives - Letai: MCEDs are a “great ideal”—alas, the data don’t support widespread use
“Projecting sub-ideal tests across a large population can cause harm,” Letai says, as Galleri cruises toward FDA approval - From “default dead” to living the future of cancer care
As founding CEO of GitLab, I went “founder mode” on my osteosarcoma - KRAS pioneer and Stephenson Prize winner Frank McCormick aims to prevent all KRAS cancers with a pill
- Anthony Letai reflects on Year One as NCI Director: “The NCI is in business”









